Full investment portfolio of the Relevant Investments as at 30 June 2020
| Relevant Investment | Type | Primary Listing | Country of Issuer | Currency | Total Cost | Mark-to-market Value | Weighting of GAV *(%) | Credit Rating (S&P's/Moody's/Fitch's) |
| KERPRO 5 ⅞ 04/06/21 | Bond | Singapore Exchange | BVI | USD | HK$67,296,000 | HK$61,043,000 | 0.0736% | - / - / - |
| NANFUN 4 ½ 09/20/22 EMTN | Bond | Singapore Exchange | BVI | USD | HK$9,797,000 | HK$9,688,000 | 0.0117% | BBB- / Baa3 / BBB- |
| NANFUN 4 ⅞ 05/29/24 EMTN | Bond | Singapore Exchange | BVI | USD | HK$56,603,000 | HK$56,789,000 | 0.0685% | BBB- / Baa3 / BBB- |
| NWDEVL 5 ¼ 02/26/21 | Bond | Hong Kong Exchange | BVI | USD | HK$41,574,000 | HK$39,475,000 | 0.0476% | - / - / - |
| PCCW 3 ¾ 03/08/23 | Bond | Singapore Exchange | BVI | USD | HK$49,641,000 | HK$50,835,000 | 0.0613% | BBB / Baa2 / - |
| CAPG 6.35 02/08/24 | Bond | Singapore Exchange | Cayman Islands | USD | HK$38,747,000 | HK$38,489,000 | 0.0464% | - / B2 / BB- |
| Union Medical Healthcare Limited (Stock Code: 2138.HK) | Equity | Hong Kong Exchange | Cayman Islands | HKD | HK$33,932,000 | HK$31,993,000 | 0.0386% | N/A |
| Total | HK$297,590,000 | HK$288,312,000 | 0.3477% | |||||